Evidence map›Paper›PMID 31004477›Full record

ArticleBiology of reproduction2019

CXCR4 signaling at the ovine fetal-maternal interface regulates vascularization, CD34+ cell presence, and autophagy in the endometrium†.

Cheyenne L Runyan, Stacia Z McIntosh, Marlie M Maestas, Kelsey E Quinn, Ben P Boren, Ryan L Ashley

Open access · greenAbstract read
In one paragraph

Article in Biology of reproduction, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Role of chemokines in early pregnancy loss.Experimental and therapeutic medicine · 2022
    Article
  12. Insight of Autophagy in Spontaneous Miscarriage.International journal of biological sciences · 2022
    Review
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Cheyenne L RunyanDepartment of Animal and Range Sciences, New Mexico State University, Las Cruces, New Mexico, USA.
Stacia Z McIntoshDepartment of Animal and Range Sciences, New Mexico State University, Las Cruces, New Mexico, USA.
Marlie M MaestasDepartment of Animal and Range Sciences, New Mexico State University, Las Cruces, New Mexico, USA.
Kelsey E QuinnDepartment of Animal and Range Sciences, New Mexico State University, Las Cruces, New Mexico, USA.
Ben P BorenDepartment of Animal and Range Sciences, New Mexico State University, Las Cruces, New Mexico, USA.
Ryan L AshleyDepartment of Animal and Range Sciences, New Mexico State University, Las Cruces, New Mexico, USA.
New Mexico State University · US

Funding

Research Education About Cancer and Health (REACH) CoreU54CA132381 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KAREN R PETERSON · 2007 to 2026
$25.3M
Undergraduate Student Training in Cancer ResearchU54CA132383 · NCI · NEW MEXICO STATE UNIVERSITY LAS CRUCES · PI MICHELE Irene SHUSTER · 2007 to 2026
$21.4M
NCI NIH HHS U54 CA132381NCI NIH HHS U54 CA132383
6 · The paper itself

Abstract

Placenta development is characterized by extensive angiogenesis and vascularization but if these processes are compromised placental dysfunction occurs, which is the underlying cause of pregnancy complications such as preeclampsia and intrauterine growth restriction. Dysregulation of placental angiogenesis has emerged as one of the main pathophysiological features in the development of placental insufficiency and its clinical consequences. The signaling axis initiated by chemokine ligand 12 (CXCL12) and its receptor CXCR4 stimulates angiogenesis in other tissues, and may be central to placental vascularization. We hypothesized that CXCL12-CXCR4 signaling governs the pro-angiogenic placental microenvironment by coordinating production of central angiogenic factors and receptors and regulates endometrial cell survival essential for placental function and subsequent fetal longevity. The CXCR4 antagonist, AMD3100, was used to elucidate the role of CXCL12-CXCR4 signaling regarding uteroplacental vascular remodeling at the fetal-maternal interface. On day 12 postbreeding, osmotic pumps were surgically installed and delivered either AMD3100 or PBS into the uterine lumen ipsilateral to the corpus luteum. On day 20, endometrial tissues were collected, snap-frozen in liquid nitrogen, and uterine horn cross sections preserved for immunofluorescent analysis. In endometrium from ewes receiving AMD3100 infusion, the abundance of select angiogenic factors was diminished, while presence of CD34+ cells increased compared to control ewes. Ewes receiving AMD3100 infusion also exhibited less activation of Akt/mTOR signaling, and elevated LC3B-II, a marker of cellular autophagy in endometrium. This study suggests that CXCL12-CXCR4 signaling governs placental homeostasis by serving as a critical upstream mediator of vascularization and cell viability, thereby ensuring appropriate placental development.

Indexed as

Maternal-Fetal ExchangeNeovascularization, PhysiologicAnimalsAntigens, CD34AutophagyCells, CulturedEndometriumFemalePlacentaPlacentationPregnancyReceptors, CXCR4SheepSignal TransductionAntigens, CD34Receptors, CXCR4angiogenesischemokinechemotaxisconceptusdomestic animal reproductionendometriumfemale reproductive tractimplantationplacentaplacentationruminantsuterus

Identifiers

PMID31004477
PMCPMC8127038
OpenAlexW2939782600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.